Werewolf Therapeutics, Inc. (HOWL): Total Assets
$69.40M
As of 2025-12-31
$24.16M
As of 2026-06-30
-24.3%
3-year compound annual growth
-6.4%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $69.40M | -45.3% | 2026-03-27, Balance as of period end |
| 2024-12-31 | $126.93M | -27.4% | 2026-03-27, Balance as of period end |
| 2023-12-31 | $174.83M | +9.1% | 2025-03-11, Balance as of period end |
| 2022-12-31 | $160.25M | -10.6% | 2024-03-07, Balance as of period end |
| 2021-12-31 | $179.25M | +85.9% | 2023-03-23, Balance as of period end |
| 2020-12-31 | $96.40M | n/a | 2022-03-24, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Werewolf Therapeutics, Inc. (HOWL) | 2025-12-31 | $69.40M | -45.3% |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $68.92M | -37.7% |
| Context Therapeutics Inc. (CNTX) | 2025-12-31 | $68.49M | -30.2% |
| Corvus Pharmaceuticals, Inc. (CRVS) | 2025-12-31 | $71.12M | +3.2% |
| Aldeyra Therapeutics, Inc. (ALDX) | 2025-12-31 | $72.06M | -31.1% |
| Grace Therapeutics, Inc. (GRCE) | 2026-03-31 | $66.65M | -7.4% |
| Incannex Healthcare Inc. (IXHL) | 2026-06-30 | $72.98M | +256.9% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $74.31M | -34.4% |
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | $76.82M | +1.6% |
Compare HOWL, SPRO, CNTX, CRVS side by side · Screen every company in Pharmaceutical Preparations ↗